Jason Pananos is a co-founder of The Nashton Company. The Nashton Company is a holding company investing in recurring revenue services businesses.  Nashton builds leading companies in niche markets over a very long period of time. 

Prior to cofounding Nashton, Jason served as the President of Vector Disease Acquisition, a holding company that provides vector-borne disease prevention programs and lake management services.  Under Jason's leadership, the company made 14 acquisitions and grew at a CAGR of 43%.  Vector Disease Acquisition was acquired by Rentokil Initial (FTSE: RTO) in November of 2017. 

Jason holds an MBA from Harvard Business School

For more on Jason or his company, please see www.nashton.com.